Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Arachidonic Acid and Masoprocol

supplement:

Arachidonic Acid

supplement:

Masoprocol

Research Papers that Mention the Interaction

Nordihydroguaiaretic acid , an inhibitor of the lipoxygenase pathway, significantly inhibited both hydrogen peroxide and arachidonic acid-stimulated c-Fos and c-Jun protein expression and AP-1 activity.
The Journal of Biological Chemistry  •  1996  |  View Paper
A LOX inhibitor, nordihydroguaiaretic acid , attenuated production of 15(S)-HETE and inhibited the phosphorylation of p38 MAPK following exposure to arachidonic acid.
Journal of Biological Chemistry  •  2005  |  View Paper
The ability of arachidonic acid to stimulate PI3K activity in neutrophils was suppressed by indomethacin and nordihydroguaiaretic acid , inhibitors of the cyclooxygenases and lipoxygenases, respectively, but not by 17-octadecynoic acid, an inhibitor of ω-hydroxylation of arachidonic acid by cytochrome P450 monooxygenases.
The Journal of Biological Chemistry  •  2001  |  View Paper
Esculetin and nordihydroguaiaretic acid inhibited formation of hepoxilin B3, 12-oxo-eicosatetraenoic acid , trioxilins, and 12-hydroxyeicosatetraenoic acid in a concentration-dependent manner.
The Journal of investigative dermatology  •  2000  |  View Paper
In contrast, the increase in adhesion to vitronectin induced by A23187 and AA was, at best, only partially inhibited by nordihydroguaiaretic acid treatment.
Cancer research  •  1996  |  View Paper
The increased rate in NNK oxidation by arachidonic acid or lipoxygenase was inhibited completely by nordihydroguaiaretic acid.
Cancer research  •  1995  |  View Paper
The arachidonic acid uptake activity was significantly reduced by the presence of indomethacin in platelets obtained from both under and over-forty year old subjects, and by the presence of nordihydroguaiaretic acid in platelets obtained from over-forty year old subjects.
Revista espanola de fisiologia  •  1995  |  View Paper
Pretreatment of LAN‐5 cells with nordihydroguaiaretic acid , a lipoxygenase inhibitor, or with indomethacin, a cyclooxygenase inhibitor, amplified the release of[3H]arachidonic acid and production of lysophosphatidylcholine induced by non‐saturating concentrations of IFN‐γ.
FEBS letters  •  1992  |  View Paper
For example, NDGA inhibited arachidonic acid-stimulated release with a 50% inhibitory concentration (IC50) of 0.39 microM for PGI2, 0.25 microM for 15-HETE, and 0.10 microM for 12-HETE.
The American journal of physiology  •  1989  |  View Paper
Nordihydroguaiaretic acid and 5,8,11,14-eicosatetraynoic acid both inhibited the conversion of arachidonic acid to 15-HETE with respective 50% inhibitory concentrations of 2.0 microM and 0.9 microM, while ATP, GTP, and cyclic AMP had no effect on activity at pH 6.8-7.2.
The Journal of investigative dermatology  •  1988  |  View Paper
Show More